Kirill Neumann

ORCID: 0009-0007-2513-0871
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Radiomics and Machine Learning in Medical Imaging
  • Lung Cancer Research Studies
  • Tracheal and airway disorders
  • Global Cancer Incidence and Screening
  • Pleural and Pulmonary Diseases
  • Neuroendocrine Tumor Research Advances
  • Clinical practice guidelines implementation
  • Cardiac tumors and thrombi
  • Atomic and Subatomic Physics Research
  • Congenital Diaphragmatic Hernia Studies
  • Airway Management and Intubation Techniques
  • Medical Imaging and Pathology Studies
  • Vascular Anomalies and Treatments
  • Brain Metastases and Treatment
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Advanced X-ray and CT Imaging
  • Autoimmune Neurological Disorders and Treatments
  • Medical Imaging Techniques and Applications
  • Pulmonary Hypertension Research and Treatments
  • Dysphagia Assessment and Management
  • Dermatological and Skeletal Disorders
  • Cancer Immunotherapy and Biomarkers
  • Amyloidosis: Diagnosis, Treatment, Outcomes

Akershus University Hospital
2019-2025

University of Oslo
2013-2015

Early Intervention Foundation
2013

Background and purpose: There is limited data on the real-world management of incidental pulmonary nodules (IPN). In this article, we review current practices adherence to international guidelines in Nordic countries. Materials methods: This non-interventional, observational survey study based an online consisting 13 questions. total, 32 hospitals responded survey, with 11 from Denmark, 10 Sweden, 7 Norway, 4 Finland, resulting overall response rate 86% (32/37). These institutions reported...

10.2340/1651-226x.2025.42461 article EN cc-by Acta Oncologica 2025-01-08

Durvalumab is an immune checkpoint Inhibitor (ICIs) that used in the treatment of malignant tumors, such as lung cancer and melanoma. ICIs are associated with immune-related adverse events including autoimmune encephalitis, although both paraneoplastic phenomena ICI may lead to autoimmunity.We describe a 72-year old male patient small-cell cancer, who during adjuvant developed GABABR1 GAD65 antibodies diabetes limbic encephalitis. Because he was followed prospectively part study, we had...

10.3389/fimmu.2023.1278761 article EN cc-by Frontiers in Immunology 2023-10-16

Background and purpose: Multi-disciplinary Team (MDT) meetings are widely regarded as the ‘gold standard’ of lung cancer care. MDTs improve adherence to clinical guidelines for patients. In this study, we describe compare in Denmark Norway by combining national surveys MDT-Metric Observation Decision-making (MDT-MODe) instrument. Materials method: Identical were sent out all MDT centers Danish Lung Cancer Group Norwegian Group. Six centers, three Norway, observed using MDT-MODe Results...

10.2340/1651-226x.2024.40777 article EN cc-by Acta Oncologica 2024-08-11

Endobronchial interventions are used to alleviate symptoms of airway stenosis. The ventilatory management may be challenging during these procedures, and influence the choice device. We report our experiences from 902 procedures.Patients undergoing interventional bronchoscopy procedures were consecutively registered 1999 2012. Critical obstruction (CAO) was defined as stridor, tracheal diameter <5 mm, stenosis both main bronchi, or clots/tumor fragments occluding trachea bronchi. Choice...

10.1097/lbr.0000000000000127 article EN Journal of Bronchology & Interventional Pulmonology 2015-01-01

8512 Background: Concurrent chemotherapy and TRT is standard treatment of LS SCLC. BID 45 Gy/30 fractions the most recommended schedule. Trials report 5-year survival rates up to 36%, illustrating that some are cured but also need for better treatment. Many failures due relapses within fields, it has been proposed higher doses might improve local control consequently survival. However, high-dose once-daily (QD) 66-70 Gy do not prolong We investigated whether 60 Gy/40 was tolerable improved...

10.1200/jco.2023.41.16_suppl.8512 article EN Journal of Clinical Oncology 2023-06-01

Background: Quality of life (QoL) has been closely linked with symptom intensity in lung cancer patients. It is therefore important to relieve respiratory distress these severely ill patients, especially because their short expectancy. This prospective study aimed evaluate the impact a therapeutic bronchoscopy on QoL, dyspnea, and function patients malignant airway obstruction. Methods: Fifteen obstruction were enrolled study. All followed up during 2 months by 4 assessments that consisted...

10.1097/lbr.0b013e3182917280 article EN Journal of Bronchology & Interventional Pulmonology 2013-04-01

8594 Background: This observational study evaluates concordance between lung cancer multi-disciplinary team (MDT) meetings, focusing on diagnosis, staging, and treatment recommendations, especially for curative options. Assessing MDT decisions aims to identify factors potentially affecting survival rates, promoting equal access patients nationwide. Methods: In Norway, with are discussed at local (without a thoracic surgeon present) university hospital (with present). All hospitals received...

10.1200/jco.2024.42.16_suppl.8594 article EN Journal of Clinical Oncology 2024-06-01

10.4172/2167-1168.1000270 article EN cc-by Journal of Nursing & Care 2015-01-01

legelivet

10.4045/tidsskr.15.1015 article NO cc-by-nd Tidsskrift for Den norske legeforening 2015-01-01

10.4045/tidsskr.18.0497 article NO cc-by-nd Tidsskrift for Den norske legeforening 2019-01-01
Coming Soon ...